Purified and recombinant forms of growth hormone (GH) as well as of recombinant rat gamma interferon (IFN--y) enhance the survival of rats deprived of endogenous pituitary GH secretion by hypophysectomy (HX rats) and infected with virulent SalmoneUla typhimurium. Macrophages obtained from rats with intact pituitaries (pituitary-intact rats) or HX rats that were treated in vivo with either GH or the closely related hormone prolactin released elevated (P < 0.05) levels of superoxide anion (02-) after in vitro opsonizedzymosan stimulation compared with those from placebo-treated animals. These levels of 02 release were similar in magnitude to those of macrophages from rats treated in vivo with IFN--y. In time course in vivo macrophage activation studies, both IFN-'y and GH significantly increased°2-secretion within 24 h, with maximal secretion occurring at day 3. Macrophages obtained from pituitary-intact and HX rats injected in vivo with GH also released elevated (P < 0.05) levels of hydrogen peroxide (H202) and displayed enhanced (P < 0.01) phagocytic activity toward opsonized Listeria monocytogenes in vitro. The mechanism of action of GH in vivo is likely to be a direct one because resident peritoneal macrophages from rats could be primed in vitro for enhanced secretion of 02 following triggering of these cells with opsonized zymosan. These data show that in vivo administration of two closely related pituitary hormones, GH and prolactin, can effectively prime macrophages, which is consistent with the hypothesis that GH mediates resistance to S. typhimurium by a direct stimulatory action on macrophages.
Macrophages can be triggered by substances such as opsonized particles and activators of protein kinase C to secrete reactive oxygen intermediates. These substances are key mediators of the inflammatory, microbicidal, and tumoricidal activities of macrophages (41) . Macrophages from animals that have been infected with bacterial organisms show an enhanced production of microbicidal oxygen metabolites upon stimulation, a phenomenon known as priming (1) . Activated macrophages are characterized by augmented secretion of reactive oxygen intermediates, so it is likely that priming is an important part of the process leading to development of activated macrophages (2) . Gamma interferon (IFN-y) is one well-characterized macrophage-activating factor that enhances in vitro and in vivo respiratory bursts of macrophages (34, 39) and increases host resistance to Salmonella typhimurium (23, 25, 32) . IFN--y increases the rate of transcription of the 91-kDa subunit of cytochrome b558 (22, 42) , which is found in specific granules of phagocytic cells and is translocated to the phagosomal membrane during cellular activation (24) . This protein is an essential component of superoxide-generating system of phagocytic cells that leads to the one-electron reduction of oxygen to superoxide anion (02-) Growth hormone (GH) and prolactin (PRL) are highly conserved members of the somatolactogenic gene family (43) . Lipopolysaccharide as well as lipopolysaccharide-induced macrophage proteins such as interleukin 1 (IL-1) and tumor necrosis factor alpha alter the synthesis and release of a number of pituitary hormones, including GH and PRL (for reviews, see references 11 and 51) . Receptors for both of these hormones have been cloned and recently designated as members of the newly defined cytokine receptor superfamily (10) , which also includes receptors for IL-2, IL-3, IL-4, IL-6, granulocyte macrophage-colony-stimulating factor, and erythropoietin. Both GH and PRL appear to be synthesized by leukocytes as well as by the pituitary gland, specific receptors for both hormones have been identified on leukocytes, and both hormones affect a number of activities of T, B, natural killer, and myeloid cells (for reviews, see references 4, 27, and 56) .
In order to compare the in vivo biological actions of GH and PRL to those of IFN--y, we have conducted a series of experiments in which these compounds were administered in vivo to both rats with intact pituitaries (pituitary-intact rats) and hypophysectomized rats (HX rats). These experiments show that both native and recombinant GHs effectively enhance the survival of HX rats challenged with virulent S. typhimurium. Peritoneal macrophages from both normal and HX rats treated in vivo with IFN-- (12, 13, 21) . Briefly, for in vitro and in vivo macrophage activation studies, pituitary-intact or HX rats were sacrificed by CO2 suffocation and macrophages were lavaged from the peritoneal cavity with 60 ml of RPMI 1640 medium containing 100 mM L-glutamine, 100 U of penicillin per ml, 100 ,ug of streptomycin per ml, and 24 mM NaHCO3 (pH 7.4) (Sigma, St. Louis, Mo.). All cell culture reagents were determined to be free of endotoxin by a chromogenic limulus amoebocyte lysate assay (M. A. Bioproducts, Walkersville, Md.). Macrophages from four rats, all from the same treatment group, were pooled and washed twice in RPMI 1640 medium (400 x g, 15 min, 4°C). These cells were plated in 24-well Nunc (Intermed) tissue culture plates at a concentration of 2 x 106 to 5 x 106 cells per ml in 2 ml of RPMI 1640 medium supplemented with 10% lowendotoxin (<25 pg/ml) fetal bovine serum (HyClone, Logan, Utah).
After a 4-h incubation period, during which time the macrophages were allowed to adhere to plastic, the medium was aspirated and 1 ml of RPMI 1640 medium supplemented with 5% fetal bovine serum was added with or without recombinant rat IFN--y (rRaIFN-y) (specific activity = (45) .
Normal controls were from the same litter. All rats were kept in quarantine for another week before initiation of experiments to allow acclimation to the laboratory. Complete hypophysectomy was confirmed by both gross and histological examination, as previously described (28; examinations of 4-,um sections that were stained with hematoxylin and eosin). Peritoneal macrophages were collected from control and treated rats on day 10 (24 h after the last injection). In the time course studies of in vivo macrophage activation by placebo (Parlow's buffer), rRaIFN--y, native pituitary-derived porcine GH (nPoGH), heat-inactivated nPoGH (70°C for 1 h), or porcine serum albumin (PSA) (Sigma), macrophages were harvested at several time periods and 02 release was measured 18 h later.
Infection experiments with S. typhimurium. Infection experiments with S. typhimurium were adapted to rats from a previously described mouse model (14) . HX rats were challenged intraperitoneally with 0.6 to 0. 
RESULTS
Recombinant IFN-y and GH protect HX rats from lethal S. typhimurium infection. HX rats were injected for 12 days with rRaIFN--y, native pituitary-derived GH from two different species, and rPoGH. Survival curves through 14 days postinfection are shown in Fig. 1 . Chi-square analysis was performed as preplanned comparisons on day 7 after infection. By this time, all rats treated with buffer had died (survivor/total = 0/36 [0%]), whereas rRaIFN--y (20/36 [56%]) and pituitary-derived GH of both porcine (10/24 [42%]) and bovine (9/24 [38%]) origin significantly enhanced (P < 0.05) survival rates. This beneficial effect of nPoGH could be directly attributed to GH because a recombinant form of this molecule (rPoGH) also significantly increased (P < 0.05) the survival rate at day 7 (8/12 [67%] ). These data confirm our recent results that porcine GH increases host resistance to S. typhimurium (16) and extend these findings to bovine GH.
Rat macrophages are primed by in vivo injection of rRaIFN-y, nRaGH, nRaPRL, or rPoGH. The next series of experiments was designed to address the question of whether macrophages from rats with intact pituitaries, and therefore normal levels of circulating GH, could be activated in vivo by injections of rat GH. We also wanted to learn whether the closely related hormone, PRL, was capable of priming macrophages from pituitary-intact and HX rats when injected in vivo. As a positive control, we tested HX rats injected with rRaIFN--y or rPoGH, both of which have been previously shown to prime rat resident peritoneal macrophages in vivo (12) . Data expected, both the native and recombinant forms of GH were biologically active, as determined by body growth. Neither rRaIFN--y nor nRaPRL augmented body growth in HX rats.
To determine whether similar results could be obtained with rats with intact pituitary glands, normal rats were treated for 9 days with rRaIFN-y (500 U per rat per day) or nRaGH, nRaPRL, or rPoGH (48 jig per rat per day). In contrast to results with HX rats, none of the hormone treatments resulted in activation of macrophages, as assessed by the release of less than 60 nmol Of 02 per mg of protein per 4 h when triggered with Op-zym in vitro. Furthermore, the lower doses of GH were not biologically active as assessed by animal growth. Injection of 500 U of IFN--y increased 02-secretion fivefold, although this increase was not statistically significant. However, macrophages from pituitary-intact rats could be significantly activated when the injected amount of rRaIFN--y was increased 5-fold and the dose of each pituitary hormone was increased 10-fold ( Table 1 ). The 02 levels released from macrophages of normal rats treated with these higher concentrations of each hormone were all significantly higher (P < 0.05) than those from rats treated with placebo and the lower dose of rRaIFN--y, nRaGH, nRaPRL, or rPoGH. The higher dose of nRaGH and nRaPRL was also biologically active, as determined by significantly increased growth rates compared with those of placebo-treated rats, and this trend was similar for rPoGH. These data are the first to show that nRaGH as well as another member of the somatolactogenic gene family, nRaPRL, are able to prime macrophages from normal rats when injected at biologically active doses in vivo. Time course studies of peritoneal macrophage activation in HX rats treated in vivo with rRaIFN-y or nPoGH. To assess the time course of macrophage activation when either IFN--y or GH is injected in vivo, several groups of noninfected HX rats were treated for 9 days with buffer, rRaIFN--y (500 U per rat per day), nPoGH (native porcine somatotropin; 48 jig per rat per day), PSA (48 jig per rat per day), or heat-inactivated nPoGH (48 jig per rat per day), a process which destroys over 60% of the bioactivity of GH (15) . On days 0, 1, 3, 6, 9, and 12, peritoneal macrophages were obtained from the treated rats, and 18 h later the in vitro Op-zym-stimulated 02 levels were measured. On day 0, no significant differences could be detected among the five treatment groups (Fig. 2) . Twenty-four hours later, macrophages obtained from rats injected with either rRaIFN--y or nPoGH had minor but statistically significant increases in the secretion of 02-compared with macrophages from rats treated with placebo, heat-inactivated nPoGH, or PSA. By day 3, injections of both rRaIFN--y and nPoGH maximally and significantly (P < 0.05) primed macrophages compared with any of the other treatments. Secretion of 02-in response to Op-zym remained significantly elevated (P < 0.05) for the following 9 days compared with results for either the placebo or PSA treatment group. It is also important that heat inactivation of nPoGH significantly attenuated priming induced by this molecule on each day of the experiment.
In vivo administration of GH increases secretion of H202. Although H202 is not a free radical, it can spontaneously lead to the formation of singlet oxygen and the hydroxyl radical. In the presence of myeloperoxidase, H202 readily forms hypochlorous acid. Therefore, we determined whether in vivo treatment with GH for 9 days would augment the ability of macrophages to secrete H202 as well as 02. As shown in Table 2 , nRaGH (48 ,ug/day) increased (P < 0.05) the secretion of H202 (to 238 + 19 nmollmg of protein per 4 h) compared with that of placebo-treated HX rats (42 + 14 nmol/mg of protein per 4 h). Similar results were obtained when 10-fold-higher concentrations of nRaGH were injected into pituitary-intact rats.
Enhanced in vitro phagocytosis by macrophages activated in vivo by rRaIFN-y or GH. Macrophages from normal or HX rats treated in vivo for 9 days with rRaIFN-y or nRaGH (at concentrations shown to induce body growth, as described above) had a significantly enhanced (P < 0.05) ability to phagocytize opsonized L. monocytogenes in vitro (Table 3) . On average, each macrophage from these two groups ingested seven more bacteria than macrophages from rats on the placebo treatment.
Rat peritoneal macrophages can be directly primed in vitro by nRaGH. Although these in vivo experiments clearly establish that nRaGH primes peritoneal macrophages to release elevated levels of 02-it is unknown whether nRaGH can act like rRaIFN--y to directly stimulate 2-secretion by rat macrophages in vitro. Therefore, it was important to learn whether GH priming of rat macrophages to release 02-could be induced directly by incubating macrophages with GH in vitro. In three separate experiments (Table 4) , resident peritoneal macrophages from HX rats incubated in vitro with nRaGH for 18 h released threeto sixfold larger amounts (P < 0.05) of 02-upon Op-zym stimulation than macrophages stimulated with Op-zym alone. These levels of 02-were comparable to the in vitro priming effects of rRaIFN--y. All responses were blocked by SOD, for which 02 is the only known substrate.
DISCUSSION
In this study, a number of experiments were conducted to evaluate the in vivo roles of IFN--y and GH in activating macrophages. It is concluded that both agents increase the resistance of rats to lethal infection with S. typhimurium and that this effect is directly related to the ability of both IFN--y VOL. 60, 1992 on January 19, 2018 by guest http://iai.asm.org/ Downloaded from and GH to activate macrophages. These conclusions are based on the findings that (i) biologically active GHs of both bovine and porcine origin can protect rats from lethal infection with S. typhimurium as well as IFN--y can; (ii) incubation medium. These results suggested, but did not prove, that the bactericidal activity of rat macrophages depended on the ability of IFN--y and GH to stimulate the secretion of toxic oxygen products. Experiments in the present report strongly support this interpretation because in vivo administration of IFN-y or various forms of biologically active GH increased host resistance to S. typhimurium while also enhancing the ability of macrophages from these animals to secrete 02 and H202 and to phagocytize opsonized microorganisms. The mechanism of action of both substances seems to be direct because both IFN-,y and GH primed rat peritoneal macrophages directly in vitro for enhanced secretion of 02-Therefore, these data offer strong support for the idea that both IFN--y and GH act in vivo to increase host resistance to S. typhimunum by activating macrophages to an antibacterial state.
The finding that rRaIFN--y enhances macrophage killing by respiratory burst oxygen intermediates is similar to those of several investigators (33, (35) (36) (37) (38) 40) . Lepay et al. (30) specifically showed that cell-mediated immunity in a murine listeriosis model is correlated with an influx of macrophages capable of generating reactive oxygen intermediates, and Buchmuller-Rouiller and Mauel (7) demonstrated that macrophage oxygen metabolism constitutes a necessary prerequisite for efficient bacterial killing. Furthermore, the ability of scavengers of reactive oxygen intermediates to partially block the killing of S. typhimurium by macrophages (16) suggests, at least for rats, the involvement of an oxygendependent killing mechanism (17) .
Since the role of oxygen-independent macrophage killing was not addressed, the possibility that GH and PRL may also up-regulate lysosomal enzymes that are also important in killing intracellular pathogens cannot be excluded (20, 44, 52) . Alternative viewpoints have also been expressed by other investigators who suggest that IFN-y activates peritoneal macrophages for tumoricidal activity but not bactericidal activity (8) ; that IFN--y cannot induce macrophage antibacterial activity against L. monocytogenes and S. typhimunium (29, 54, 55) ; that in vitro IFN--y-induced macrophage Salmonella killing is mainly due to an oxygen-independent killing mechanism (25); and, finally, that bacterial lipopolysaccharide is needed in addition to IFN-,y to afford the host enhanced protection (32) . Perhaps these disparate results are due to the use of a S. typhimurium strain with enhanced or decreased macrophage virulence (18, 57) , the age of growth phase bacterial culture (3), the existence of resistance plasmids (53) , the enhanced expression of selected Salmonella heat shock proteins (6), or species differences between mice and rats (26) .
The newly defined family of receptors for a number of cytokines include PRL as well as GH receptors. All of these receptors contain the conserved feature of two pairs of cysteines in their extracellular domain and include receptors for IL-2, IL-3, IL-4, IL-6, granulocyte macrophage-colonystimulating factor, and erythropoietin (10) . Because of the strong homology between GH and PRL receptors, it was important to learn whether these closely related hormones would act similarly to prime macrophages in vivo for an enhanced respiratory burst. In addition to GH, PRL has also been shown to increase the resistance of rodents to lethal infection with L. monocytogenes (5) . Very recently, PRL has been shown to prime human neutrophils for 02 secretion (19) and to be critically involved in the IL-2-driven proliferation of T lymphocytes (9) . The priming effect of PRL in vitro is similar to that of GH as identified by us (19) and others (58, 59) . Data in the present experiments clearly establish that both GH and PRL prime phagocytic cells in vivo in a manner similar to that of IFN-,y. Even though IFN--y is much more effective than GH on a molar basis, GH does prime phagocytic cells at concentrations that augment body growth in HX rats. Although 10-fold-higher concentra- secretion.
